Insider Transactions in Q3 2022 at Epizyme, Inc. (EPZM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2022
|
Michael F Giordano Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,054
-73.63%
|
-
|
|
Aug 12
2022
|
Carl Goldfischer Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,380,951
-100.0%
|
-
|
|
Aug 12
2022
|
Carl Goldfischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,054
-79.61%
|
-
|
|
Aug 12
2022
|
Victoria Richon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,608
-80.11%
|
-
|
|
Aug 12
2022
|
David M Mott Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
106,959
-100.0%
|
-
|
|
Aug 12
2022
|
David M Mott Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,994
-100.0%
|
-
|
|
Aug 12
2022
|
David M Mott Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
215,494
-95.99%
|
-
|
|
Aug 12
2022
|
Legorreta Pablo G. Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
31,933,334
-100.0%
|
-
|
|
Aug 12
2022
|
Jeffery Kutok Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,067
-66.26%
|
-
|
|
Aug 12
2022
|
Carol Stuckley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,696
-100.0%
|
-
|
|
Aug 12
2022
|
Kevin T Conroy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,318
-92.78%
|
-
|
|
Aug 12
2022
|
Grant C. Bogle President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
259,170
-66.24%
|
-
|
|
Aug 12
2022
|
Joseph Beaulieu Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,076
-78.98%
|
-
|
|
Aug 12
2022
|
Beveridge, Roy A Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,037
-72.09%
|
-
|
|
Aug 12
2022
|
Kenneth Bate Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,054
-73.63%
|
-
|
|
Aug 12
2022
|
Shefali Agarwal |
SELL
Sale (or disposition) back to the issuer
|
Direct |
286,539
-81.28%
|
-
|
|
Aug 09
2022
|
Jeffery Kutok Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
354,496
-74.7%
|
$354,496
$1.39 P/Share
|
|
Aug 09
2022
|
Jeffery Kutok Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
380,000
+44.47%
|
$380,000
$1.39 P/Share
|
|
Aug 09
2022
|
Grant C. Bogle President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,141,390
-68.15%
|
$1,141,390
$1.4 P/Share
|
|
Aug 09
2022
|
Grant C. Bogle President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,217,500
+41.91%
|
$1,217,500
$1.4 P/Share
|
|
Aug 09
2022
|
Joseph Beaulieu Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
279,864
-84.56%
|
$279,864
$1.39 P/Share
|
|
Aug 09
2022
|
Joseph Beaulieu Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+47.55%
|
$300,000
$1.39 P/Share
|
|
Aug 09
2022
|
Shefali Agarwal |
SELL
Payment of exercise price or tax liability
|
Direct |
373,154
-56.65%
|
$373,154
$1.39 P/Share
|
|
Aug 09
2022
|
Shefali Agarwal |
BUY
Exercise of conversion of derivative security
|
Direct |
500,000
+24.32%
|
$500,000
$1.39 P/Share
|